RAPGEF3 and prostate cancer: In prostate cancer cells, this analog causes upregulation of Epac1, Rap1GTP, protein synthesis, DNA synthesis, and MAPK, and PI 3-kinase-Akt-mTORC1-mTORC2 signaling.